causal
Underfunded Linear Biotech Bets Fail to Adapt
An early investment in a small cancer drug company failed because it was a linear plan with a small team and insufficient funding, leaving no degrees of freedom to adjust when reality diverged from the plan.
causalpending
Speaker
Tal ZaksEvidence Quote
“this was probably not well enough funded and not given enough opportunity, either with the team structure or the financial structure or the scientific structure to have that degrees and freedom to adjust.”
Created: 11/19/2026, 4:01:33 PM
Your notes
Loading notes...